Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleSpondyloarthritis

The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study

Anne C. Regierer, Anja Weiß, Uta Kiltz, Joachim Sieper, Ilka Schwarze, Martin Bohl-Bühler, Herbert Kellner, Denis Poddubnyy, Angela Zink, Jürgen Braun, Joachim Listing and Anja Strangfeld
The Journal of Rheumatology February 2023, 50 (2) 185-191; DOI: https://doi.org/10.3899/jrheum.220212
Anne C. Regierer
1A.C. Regierer, MD, PhD, A. Weiß, PhD, J. Listing, PhD, German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne C. Regierer
  • For correspondence: anne.regierer@drfz.de
Anja Weiß
1A.C. Regierer, MD, PhD, A. Weiß, PhD, J. Listing, PhD, German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anja Weiß
Uta Kiltz
2U. Kiltz, MD, PhD, J. Braun, MD, PhD, Rheumazentrum Ruhrgebiet, Herne, and Ruhr-University Bochum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Uta Kiltz
Joachim Sieper
3J. Sieper, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joachim Sieper
Ilka Schwarze
4I. Schwarze, MD, Private Rheumatology Practice, Leipzig;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Bohl-Bühler
5M. Bohl-Bühler, MD, Private Rheumatology Practice, Potsdam;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herbert Kellner
6H. Kellner, MD, PhD, Private Rheumatology Practice, Munich;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Poddubnyy
7D. Poddubnyy, MD, PhD, Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, and German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Denis Poddubnyy
Angela Zink
8A. Zink, PhD, A. Strangfeld, MD, PhD, German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin, and Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Braun
2U. Kiltz, MD, PhD, J. Braun, MD, PhD, Rheumazentrum Ruhrgebiet, Herne, and Ruhr-University Bochum;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim Listing
1A.C. Regierer, MD, PhD, A. Weiß, PhD, J. Listing, PhD, German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anja Strangfeld
8A. Zink, PhD, A. Strangfeld, MD, PhD, German Rheumatism Research Center (DRFZ Berlin), Epidemiology and Health Care Research, Berlin, and Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anja Strangfeld
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective The Assessment of Spondyloarthritis international Society Health Index (ASAS HI) measures global functioning and health in patients with axial spondyloarthritis (axSpA) covering domains of physical, emotional, and social functioning. The main aim of this study was to investigate the sensitivity to change of ASAS HI in comparison with established variables of disease activity, function, and mental health.

Methods Patients with axSpA from the disease register RABBIT-SpA with follow-up time of at least 12 months and available ASAS HI questionnaires were included. Patients received questionnaires addressing disease activity (Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Ankylosing Spondylitis Disease Activity Score [ASDAS]), physical function (Bath Ankylosing Spondylitis Functional Index [BASFI]), mental health (5-item World Health Organization Well-Being Index [WHO-5]), and global functioning (ASAS HI). Standardized response means (SRMs) were calculated to compare the sensitivity to change of different variables.

Results Six hundred and sixty-seven patients were included, 552 treated with biologic disease-modifying antirheumatic drugs (bDMARDs) and 115 with conventional synthetic DMARDs and/or nonsteroidal antiinflammatory drugs (control group). Between baseline and month 12, the mean ASAS HI declined from 6.9 to 5.1 in the bDMARD group and from 5.9 to 5.6 in the conventionally treated group. In the bDMARD group, the SRM of ASAS HI was 0.52, compared to 0.59 for BASFI, 0.65 for WHO-5, 0.73 for BASDAI, and 0.90 for ASDAS. The following ASAS HI domains were most frequently affected: pain (78% agreed), maintaining body position (75%), and energy/drive (73%). In the patients receiving bDMARDs, there was an improvement in all items. In the control group, the largest improvement was seen in pain.

Conclusion As expected, ASDAS and BASDAI as disease activity scores showed high sensitivity to change, whereas changes in physical function (BASFI), mental health (WHO-5), and the broader concept of functioning and health (ASAS HI) were moderate.

Key Indexing Terms:
  • ankylosing spondylitis
  • cohort study
  • outcome measure
  • Accepted for publication July 20, 2022.
  • Copyright © 2023 by the Journal of Rheumatology
View Full Text

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
Anne C. Regierer, Anja Weiß, Uta Kiltz, Joachim Sieper, Ilka Schwarze, Martin Bohl-Bühler, Herbert Kellner, Denis Poddubnyy, Angela Zink, Jürgen Braun, Joachim Listing, Anja Strangfeld
The Journal of Rheumatology Feb 2023, 50 (2) 185-191; DOI: 10.3899/jrheum.220212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study
Anne C. Regierer, Anja Weiß, Uta Kiltz, Joachim Sieper, Ilka Schwarze, Martin Bohl-Bühler, Herbert Kellner, Denis Poddubnyy, Angela Zink, Jürgen Braun, Joachim Listing, Anja Strangfeld
The Journal of Rheumatology Feb 2023, 50 (2) 185-191; DOI: 10.3899/jrheum.220212
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

ANKYLOSING SPONDYLITIS
COHORT STUDY
OUTCOME MEASURE

Related Articles

Cited By...

More in this TOC Section

  • Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study
  • Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
  • Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis
Show more Spondyloarthritis

Similar Articles

Keywords

  • ankylosing spondylitis
  • cohort study
  • outcome measure

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire